Delivery Order SPE2DB22D2006-SPE2DB24FV5TG
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,032.94 Firm Fixed Price Delivery Order is for the supply of 4554822494 - POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of September 20, 2021 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves...
- This federal contract award, valued at $7,993.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of POSACONAZOLE DR 100 MG TABLET UD 20S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Posaconazole 200 mg/5 ml suspension. The $1,864.78 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,263.06 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 60 posaconazole 100 mg tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 14, 2023. No set-aside designation was applied to this order placed pursuant to DLA's pharmaceutical supply contracts. Amerisourcebergen routinely provides...
- The Defense Logistics Agency awarded a $2,093.73 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Posaconazole 100 mg, an antifungal medication commonly used in military and veteran healthcare settings. This competitively awarded, firm fixed-price contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside...
- This federal contract award is for the delivery of Voriconazole 200 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 3, 2024 with a ceiling value of $2,828.81. The contract has an ultimate completion date of January 4, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,092.73 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a completion date of December 29, 2023. This award is not designated as a set-aside contract. The DLA, which is a defense agency, is the contracting authority for this order,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $43,475.37, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 3, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,837.50 firm-fixed-price delivery order contract has an ultimate completion date of October 30, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract has a ceiling value of $1,856.40 and an ultimate completion date of August 15, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV5TGDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,681.08, is a delivery order for 4562560501 - POSACONAZOLE DR 100 MG TABLET 60S. It is a firm fixed-price contract with an ultimate completion date of October 24, 2023. The contract was awarded on October 23, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/23/23 |